Evidence map›Paper›PMID 25225433›Full record

ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2014

Responsibility for costs associated with clinical trials.

Paul J Martin, Nancy Davenport-Ennis, Nicholas J Petrelli, F Marc Stewart, Frederick R Appelbaum, Al Benson

Abstract read
In one paragraph

Article in Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Fair payment and just benefits to enhance diversity in clinical research.Journal of clinical and translational science · 2021
    Article
  3. From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2018
    Article
  4. Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Paul J MartinFred Hutchinson Cancer Research Center and University of Washington, Seattle, WA pmartin@fhcrc.org.
Nancy Davenport-EnnisNational Patient Advocate Foundation, Washington, DC.
Nicholas J PetrelliHelen F. Graham Cancer Center and Research Institute at Christiana Care Health System, Newark, DE; Thomas Jefferson University, Philadelphia, PA.
F Marc StewartFred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.
Frederick R AppelbaumFred Hutchinson Cancer Research Center and University of Washington, Seattle, WA.
Al BensonRobert H. Lurie Comprehensive Cancer Center, Northwestern University, Feinberg School of Medicine, Chicago, IL.

Funding

X-Ray Crystallography and Macromolecular CharacterizationP30CA056036 · NCI · THOMAS JEFFERSON UNIVERSITY · PI DANIEL P SILVER · 1995 to 2026
$94.8M
NCI NIH HHS P30 CA056036
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Health Care CostsClinical Trials as TopicHumansMedicarePatient Protection and Affordable Care ActUnited States

Identifiers

PMID25225433
PMCPMC4876354

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.